Chimeric antigen receptor T-cell therapy for mantle cell lymphoma with central nervous system involvement: Progress, but not perfect

被引：2
|
作者：
Lewis, Katharine L. [1 ,2 ,3 ]
Cheah, Chan Y. [1 ,2 ,3 ]
机构：
[1] Linear Clin Res, Nedlands, WA, Australia
[2] Sir Charles Gairdner Hosp, Dept Haematol, Nedlands, WA, Australia
[3] Univ Western Australia, Nedlands, WA, Australia
来源：
BRITISH JOURNAL OF HAEMATOLOGY | 2023年 / 203卷 / 05期
关键词：
D O I：
10.1111/bjh.19095
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：701 / 703
页数：3
相关论文
共 50 条
  • [21] Chimeric Antigen Receptor T-Cell Therapy
    Ogba, Ndiya
    Arwood, Nicole M.
    Bartlett, Nancy L.
    Bloom, Mara
    Brown, Patrick
    Brown, Christine
    Budde, Elizabeth Lihua
    Carlson, Robert
    Farnia, Stephanie
    Fry, Terry J.
    Garber, Morgan
    Gardner, Rebecca A.
    Gurschick, Lauren
    Kropf, Patricia
    Reitan, Jeff J.
    Sauter, Craig
    Shah, Bijal
    Shpall, Elizabeth J.
    Rosen, Steven T.
    JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2018, 16 (09): : 1093 - 1106
  • [22] Combining forces for good: chimeric antigen receptor T-cells and Bruton tyrosine kinase inhibitors in mantle cell lymphoma with central nervous system involvement
    Minson, Adrian
    Dickinson, Michael
    LEUKEMIA & LYMPHOMA, 2024, 65 (05) : 546 - 547
  • [23] Chimeric Antigen Receptor T-Cell Therapy
    Rasheed, Azgar Abdul
    Koyyala, Venkata Pradeep Babu
    INDIAN JOURNAL OF MEDICAL AND PAEDIATRIC ONCOLOGY, 2021, 42 (01) : 89 - 92
  • [24] Chimeric Antigen Receptor T-Cell Therapy in Aggressive B-Cell Lymphoma
    Hamilton, Mark P.
    Miklos, David B.
    HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 2023, 37 (06) : 1053 - 1075
  • [25] Benefits of Chimeric Antigen Receptor T-Cell Therapy for B-Cell Lymphoma
    Zhou, Wenyujing
    Chen, Weihong
    Wan, Xiaochun
    Luo, Changru
    Du, Xin
    Li, Xiaoqing
    Chen, Qian
    Gao, Ruiwen
    Zhang, Xiaohan
    Xie, Mei
    Wang, Mingjun
    FRONTIERS IN GENETICS, 2022, 12
  • [26] Chimeric antigen receptor T-cell therapies for lymphoma
    Brudno, Jennifer N.
    Kochenderfer, James N.
    NATURE REVIEWS CLINICAL ONCOLOGY, 2018, 15 (01) : 31 - 46
  • [27] Chimeric antigen receptor T-cell therapies for lymphoma
    Jennifer N. Brudno
    James N. Kochenderfer
    Nature Reviews Clinical Oncology, 2018, 15 : 31 - 46
  • [28] Evaluation of central nervous system involvement in patients undergoing chimeric antigen receptor-engineered T-cell therapy by magnetic resonance imaging
    Choque-Chavez, F. D.
    Jareno-Badenas, A.
    Benitez-Ribas, D.
    Oleaga, L.
    RADIOLOGIA, 2025, 67 (01): : 91 - 95
  • [29] Outcomes of patients with primary central nervous system lymphoma following CD19-targeted chimeric antigen receptor T-cell therapy
    Mercadal, Santiago
    Ahn, Kwang Woo
    Allbee-Johnson, Mariam
    Ganguly, Siddhartha
    Geethakumari, Praveen Ramakrishnan
    Hong, Sanghee
    Malone, Adriana
    Murthy, Hemant
    Pawarode, Attaphol
    Sica, R. Alejandro
    Solh, Melhem
    Ustun, Celalettin
    Shadman, Mazyar
    Sauter, Craig S.
    Hamadani, Mehdi
    Herrera, Alex F.
    Lee, Catherine J.
    HAEMATOLOGICA, 2025, 110 (01) : 218 - 221
  • [30] Chimeric Antigen Receptor T - Cell Therapy for Large B-Cell Lymphoma Patients with Central Nervous System Involvement, a Systematic Review and Meta-analysis
    Elgohary, Ghada
    Yang, Yang
    Gergis, Mia
    Yi, Dongni
    Gergis, Usama
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2024, 24 (04): : e142 - e151
12345